QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: mol.106.029967v1 70/6/1935    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Paillasse, M. R. Articles by Silvente-Poirot, S. Search for Related Content PubMed PubMed Citation Articles by Paillasse, M. R. Articles by Silvente-Poirot, S.

Insights into the Cholecystokinin 2 Receptor Binding Site and Processes of Activation

Institut National de la Santé et de la Recherche Médicale U563, Equipe: Métabolisme, Oncogenèse et différenciation cellulaire, Institut Claudius Regaud, Toulouse, France (C.D., L.M., G.F., M.P., S.S.-P.); and Affichem, Institut Claudius Regaud, Toulouse, France (M.R.P., P.D.M.).

The cholecystokinin (CCK) 2 receptor (CCK2R) appears as a pharmacological target for the treatment of many major diseases. To complete the mapping of the CCK2R binding site and its activation processes, we have looked for the receptor residues that interact with Trp6, an essential residue for CCK binding and activity. In our molecular model of the CCK-occupied CCK2R, the indole group of Trp6 stacked with the phenyl ring of Phe120 (ECL1) and interacted with the imidazole group of His381(H7.39) and the phenyl ring of Tyr385(H7.43). Mutagenesis and pharmacological studies validated these interactions. It is noteworthy that the mutation of Phe120 to Trp conferred constitutive activity to the CCK2R. Molecular modeling and experimental works identified the residues involved in the activation cascade initiated by Trp6 and revealed that the constitutively active F120W mutation mimics the conformational changes induced by Trp6 resulting in: 1) the exposure of Glu151(E3.49) of the conserved E/DRY motif 2) the formation of an amphiphatic pocket involving protonated Glu151(E3.49) and Leu330 (ICL3), and 3) the opening of the intracellular loops 2 and 3 and the release of Arg158 (ICL2). The R158A mutation was shown to affect inositol phosphate production, whereas the E151A and L330E mutations induced constitutive inositol phosphate production. Given that a constitutively active variant of the CCK2R has been identified in different cancers and the fact that the E151A mutant has been reported to induce tumors, these studies should help in the development of potent inverse agonists to inhibit the constitutive activation of the CCK2R.

Address correspondence to: Dr. Sandrine Silvente-Poirot, INSERM U563, Equipe: Métabolisme, Oncogenèse et différenciation cellulaire, Institut Claudius Regaud, 20-24 rue du Pont Saint Pierre, 31052 Toulouse Cedex, France. E-mail: poirot.sandrine{at}claudiusregaud.fr

This article has been cited by other articles:

				N. Gonzalez, S. J. Hocart, S. Portal-Nunez, S. A. Mantey, T. Nakagawa, E. Zudaire, D. H. Coy, and R. T. Jensen Molecular Basis for Agonist Selectivity and Activation of the Orphan Bombesin Receptor Subtype 3 Receptor J. Pharmacol. Exp. Ther., February 1, 2008; 324(2): 463 - 474. [Abstract] [Full Text] [PDF]